Skip to content

EV / EBITDA at other companies

LivaNova logo
LivaNovaLIVN
13.6×+3.1×
ICU Medical logo
ICU MedicalICUI
17.4×+0.4×
Edwards Lifesciences logo
Edwards LifesciencesEW
29.5×+4.1×
OSI Systems logo
OSI SystemsOSIS
19.6×+5.0×

Other financials

Income statement

See full
Revenue$173.9M+21.2%
Gross profit$101.2M+14.7%
Operating income$13.3M-51.5%
Net income$7.3M-71.5%
EPS (diluted)$0.20-71.4%

Balance sheet

See full
Cash & equivalents$461.7M+48.9%
Total debt$409.9M+505%
Total equity$494.0M+85.5%
Total assets$1.4B+71.3%

Cash flow

See full
Operating cash flow$24.5M+959%
CapEx$36.7M+35.6%
Free cash flow-$12.1M+59.4%

Valuation

See full
Market cap$2.55B+50.6%
Enterprise value$2.5B+66.0%
P/E14.8×-19.8×
P/S+0.5×

Profitability

See full
Gross margin59.1%-0.4pp
Operating margin14.9%+4.1pp
Net margin27%+17.0pp
FCF margin23.8%

Returns & leverage

See full
Return on equity45.2%+22.2pp
Debt / equity0.8×+0.6×
Current ratio6.7×-2.4×

Where this comes from

Calculated from TransMedics Group, Inc.’s reported figures.

Based on the most recent quarter.

The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransMedics Group, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TransMedics Group, Inc.'s EV / EBITDA?
TransMedics Group, Inc. (TMDX) reported EV / EBITDA of 26.4× in Q1 2026.
How has TransMedics Group, Inc.'s EV / EBITDA changed year-over-year?
TransMedics Group, Inc.'s EV / EBITDA decreased by 3.4% year-over-year, from 27.3× to 26.4×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.